The FIVE Institute is guided by a vision in which the full therapeutic and scientific potential of 5-MeO-DMT is responsibly realized. We are committed to advancing evidence-based approaches that deepen understanding of this molecule, combining the expertise of leading researchers, clinicians and legacy practitioners with the latest advances in science.
Our work spans both naturalistic and clinical research, conducted in partnership with institutional collaborators including Imperial College London and UCL, and extends to advisory support for clinical and pharmaceutical development. Data and real-world evidence drive new training methods, educational content, protocols, and product development pathways.